By Eric Schweibenz
On August 9, 2012, ALJ Thomas B. Pender issued Order No. 36 granting Complainants Standard Innovation (US) Corp. and Standard Innovation Corporation (collectively, “Standard”) and Respondent Momentum Management, LLC a.k.a. Bushman Products’ (“Bushman”) joint motion to terminate the investigation in Certain Kinesiotherapy Devices and Components Thereof (Inv. No. 337-TA-823).

According to the Order, Bushman entered into a stipulation and consent order.  ALJ Pender found that the stipulation complied with the requirements of Commission Rule 210.21(c)(3).  The ALJ further found that, pursuant to Commission Rule 210.50(b)(2), the termination of the investigation on the basis of the consent order is in the public interest and does not impose any undue burdens on the public health and welfare, competitive conditions in the U.S. economy, the production of like or directly competitive articles in the U.S., or U.S. consumers.